112 related articles for article (PubMed ID: 2741194)
1. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum sampling methods for determining vancomycin dosage regimens.
Albrecht LM; Rybak MJ; Boike SC; Pancorbo S
Ther Drug Monit; 1988; 10(1):85-90. PubMed ID: 3376187
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
[TBL] [Abstract][Full Text] [Related]
6. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Fernández de Gatta MM; Fruns I; Domínguez-Gil A
Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
[TBL] [Abstract][Full Text] [Related]
7. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
Killilea T; Coleman R; Ludden T; Peck CC; Rose D
Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
[TBL] [Abstract][Full Text] [Related]
9. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
11. Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategies.
Rodvold KA; Rotschafer JC; Gilliland SS; Guay DR; Vance-Bryan K
Ther Drug Monit; 1994 Feb; 16(1):37-41. PubMed ID: 8160252
[TBL] [Abstract][Full Text] [Related]
12. Computer dosing program for the initiation of vancomycin therapy.
Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
Godley PJ; Black JT; Frohna PA; Garrelts JC
Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
15. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
16. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
McClellan SD; Farringer JA
Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
[TBL] [Abstract][Full Text] [Related]
17. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
18. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.
Godley PJ; Ludden TM; Clementi WA; Godley SE; Ramsey RR
Clin Pharm; 1987 Aug; 6(8):634-9. PubMed ID: 3691009
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin monitoring: one or two serum levels?
Andrés I; López R; Pou L; Piñol F; Pascual C
Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]